SCHEMBL6232468

SCHEMBL6232468

Cc1ccc(CN2CCN(c3ccc4ccccc4n3)CC2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 6/20 0.66
ALDH1A1 P00352 4/20 0.58
HTR3A P46098 3/20 0.58
KDM4E B2RXH2 3/20 0.58
HTR3E A5X5Y0 2/20 0.58
HTR3B O95264 2/20 0.58
CYP1A2 P05177 2/20 0.58
HTR3D Q70Z44 2/20 0.58
HTR3C Q8WXA8 2/20 0.58
THPO P40225 1/20 0.58
HRH4 Q9H3N8 1/20 0.58
LMNA P02545 2/20 0.56
POLB P06746 1/20 0.56
NPC1 O15118 4/20 0.54
RAB9A P51151 4/20 0.54
HTR1A P08908 3/20 0.53
TDP1 Q9NUW8 2/20 0.51
USP2 O75604 1/20 0.51
ADRB1 P08588 1/20 0.51
CYP3A4 P08684 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6234227 0.99 HRH3 (0.64) HRH3ALDH1A1HTR3AKDM4EHTR3E
SCHEMBL6228769 0.89 HRH3 (0.70) HRH3ALDH1A1HTR3AKDM4EHTR3E
SCHEMBL6231596 0.89 HRH3 (0.68) HRH3ALDH1A1HTR3AKDM4EHTR3E
SCHEMBL6229963 0.88 HRH3 (0.63) HRH3ALDH1A1HTR3AKDM4EHTR3E
Bromide SCHEMBL6232431 0.86 HRH3 (0.62) HRH3ALDH1A1HTR3AKDM4EHTR3E
SCHEMBL27528331 0.86 HRH3 (0.62) HRH3ALDH1A1HTR3AKDM4EHTR3E
SCHEMBL6229177 0.86 HRH3 (0.62) HRH3ALDH1A1HTR3AKDM4EHTR3E
SCHEMBL6230285 0.86 HRH3 (0.61) HRH3ALDH1A1HTR3AKDM4EHTR3E
Hydrochloric Acid SCHEMBL27494769 0.85 HRH3 (0.60) HRH3ALDH1A1HTR3AKDM4EHTR3E
Hydrochloric Acid SCHEMBL6230865 0.85 HRH3 (0.60) HRH3ALDH1A1HTR3AKDM4EHTR3E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1025097-B1 1-(2-NAPHTHYL) AND 1-(2-AZANAPHTHYL)-4-(1-PHENYLMETHYL)PIPERAZINES BEING DOPAMINE D 4? RECEPTOR SUBTYPE LIGANDS NEUROGEN CORP (US) 2005-04-27 EP claimed
US-20020013317-A1 Certain 1- (2-naphthyl) and 1- (2- azanaphthyl) -4- (1-phenylmethyl) piperazines; dopamine receptor subtype specific ligands NEUROGEN CORPORATION 2002-01-31 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020013317-A1 Certain 1- (2-naphthyl) and 1- (2- azanaphthyl) -4- (1-phenylmethyl) piperazines; dopamine receptor subtype specific ligands DRD2, DRD4, DRD3 HRH3 137/4885ALDH1A1 976/4885HTR3A 43/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.